Explore

Trendline Trendline
FDA Approves New Sunscreen Ingredient Bemotrizinol, Enhancing U.S. Sun Protection Options

FDA Approves New Sunscreen Ingredient Bemotrizinol, Enhancing U.S. Sun Protection Options

FDA Approves New Sunscreen Ingredient Bemotrizinol, Enhancing U.S. Sun Protection Options
Trendline Trendline
FDA Approves Bemotrizinol, Expanding Sunscreen Options in the U.S.

FDA Approves Bemotrizinol, Expanding Sunscreen Options in the U.S.

FDA Approves Bemotrizinol, Expanding Sunscreen Options in the U.S.
Rapid Read Rapid Read
FDA Approves Bemotrizinol, Expanding Sunscreen Options for U.S. Consumers

FDA Approves Bemotrizinol, Expanding Sunscreen Options for U.S. Consumers

The Food and Drug Administration (FDA) has approved bemotrizinol, a new sunscreen ingredient, marking the first addition to the list of approved sunscreen filters in over 20 years. Bemotrizinol, which has been used in Europe and Asia for decades, is recognized for its ability to protect against both UVA and UVB rays. The ingredient is considered Generally Recognized As Safe and Effective (GRASE) by the FDA and is suitable for use by adults and children over six months old. This approval is expected to enhance the effectiveness of U.S. sunscreens, which have traditionally been less effective against UVA rays compared to their international counterparts.
Rapid Read Rapid Read
FDA Approves New Sunscreen Ingredient BEMT, Offering Safer Options for Consumers

FDA Approves New Sunscreen Ingredient BEMT, Offering Safer Options for Consumers

The Food and Drug Administration (FDA) has approved a new sunscreen ingredient known as BEMT, marking the first approval of its kind in 20 years. This ingredient is considered a safer alternative to many of the chemical additives currently used in sunscreens available in the U.S. The approval of BEMT is part of an ongoing effort to enhance the safety and effectiveness of sunscreen products, which are essential for protecting skin from harmful UV rays. The introduction of BEMT is expected to provide consumers with more options and potentially reduce the risk of skin irritation and other adverse effects associated with existing sunscreen ingredients.
Vox Vox
The US just got its first new sunscreen in almost 30 years

The US just got its first new sunscreen in almost 30 years

America’s sunscreens have been stuck in the past. With BEMT, that's finally changing.
AP News AP News
FDA OKs first new sunscreen ingredient in more than 25 years

FDA OKs first new sunscreen ingredient in more than 25 years

Federal health regulators have signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years
Rapid Read Rapid Read
FDA Approves Bemotrizinol, Enhancing U.S. Sunscreen Options

FDA Approves Bemotrizinol, Enhancing U.S. Sunscreen Options

The FDA has approved bemotrizinol for use in U.S. sunscreens, marking the first new sunscreen ingredient approval since the 1990s. Bemotrizinol, already popular in Europe, offers broad-spectrum protection against UVA and UVB rays and is more photostable than existing ingredients. The approval was expedited under the CARES Act, aiming to improve consumer access to effective sun protection. The ingredient is expected to be available in U.S. products starting August 2026, initially through DSM Nutritional Products, with broader availability following an 18-month exclusivity period.
Rapid Read Rapid Read
FDA Approves Bemotrizinol, First New Sunscreen Ingredient in the U.S. in Decades

FDA Approves Bemotrizinol, First New Sunscreen Ingredient in the U.S. in Decades

The United States has approved bemotrizinol, a new sunscreen ingredient, marking the first such approval in nearly 30 years. Bemotrizinol, known as BEMT, has been used in Europe and Asia but was delayed in the U.S. due to regulatory processes. The FDA's approval follows a congressional mandate to overhaul the sunscreen approval process. BEMT offers broad-spectrum protection against UVA and UVB rays and is expected to be more cosmetically appealing, addressing concerns about chemical sunscreens. The Environmental Working Group and dermatologists have hailed this approval as a significant advancement in sun protection.
Rapid Read Rapid Read
FDA Approves New Sunscreen Ingredient Bemotrizinol After Two Decades

FDA Approves New Sunscreen Ingredient Bemotrizinol After Two Decades

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol as a new active ingredient for over-the-counter sunscreens, marking the first such approval in 20 years. This decision is part of the FDA's efforts to modernize its regulatory processes and promote innovation in the sunscreen market. Bemotrizinol, which has been used in Europe for years, offers protection against both UVA and UVB rays and is considered safe for use by adults and children over six months old. The approval follows a streamlined process established by the CARES Act, allowing for more efficient market entry of new products.
Trendline Trendline
FDA Approves Bemotrizinol, a Popular Korean Sunscreen Ingredient, for U.S. Use

FDA Approves Bemotrizinol, a Popular Korean Sunscreen Ingredient, for U.S. Use

FDA Approves Bemotrizinol, a Popular Korean Sunscreen Ingredient, for U.S. Use
Rapid Read Rapid Read
FDA Approves Bemotrizinol, First New Sunscreen Ingredient in Decades

FDA Approves Bemotrizinol, First New Sunscreen Ingredient in Decades

The FDA has approved bemotrizinol, a sunscreen ingredient used in Europe and Asia, marking the first new sunscreen ingredient approval in the U.S. since the 1990s. Bemotrizinol is a chemical UV filter that absorbs both UVA and UVB rays, offering more effective protection against skin cancer and wrinkles. The approval follows advocacy from dermatology groups and aims to enhance consumer confidence in sunscreen products. The ingredient is expected to be available in U.S. sunscreens starting August 2026, initially under the brand name Parsol Shield by DSM Nutritional Products.
Rapid Read Rapid Read
FDA Approves Bemotrizinol, Expanding U.S. Sunscreen Options

FDA Approves Bemotrizinol, Expanding U.S. Sunscreen Options

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol as a new active ingredient for sunscreens, the first such approval since the 1990s. Bemotrizinol is known for its ability to absorb both UVA and UVB rays, offering broad-spectrum protection. It is more photostable than other ingredients, meaning it breaks down more slowly in sunlight. The ingredient is safe for use by adults and children as young as six months, with low absorption into the body, making it suitable for sensitive skin. This approval follows advocacy from dermatology groups and aims to provide U.S. consumers with more effective sun protection options.